Literature DB >> 9950810

Role of nitric oxide in fasting gastric fundus tone and in 5-HT1 receptor-mediated relaxation of gastric fundus.

B Coulie1, J Tack, D Sifrim, A Andrioli, J Janssens.   

Abstract

Fasting gastric fundus tone is maintained by continuous cholinergic input. 5-Hydroxytryptamine-1 (5-HT1) receptor activation decreases gastric fundus tone in humans. Whether this fundus-relaxing effect is mediated via inhibition of cholinergic input or via activation of a nitrergic pathway is unknown. The aim of the present study was to determine the effect of nitrergic inhibition on feline gastric fundus tone and on 5-HT1 receptor-mediated relaxation of the fundus. Administration of Nomega-nitro-L-arginine methyl ester (L-NAME) alone caused a significant decrease of the mean baseline volume (P < 0.005), which was restored completely by addition of L-arginine. Sumatriptan caused a dose-dependent relaxation of the gastric fundus (P < 0.0005). This relaxation was inhibited by L-NAME (P < 0.02) and was restored by prior administration of L-arginine. Buspirone did not cause any change in mean baseline volume, whereas the sumatriptan-induced relaxation was not affected by prior administration of NAN-190. Our data indicate that fasting fundus tone relies not only on continuous cholinergic input but also on continuous nitrergic input, implying that fasting fundus tone is maintained by the balance of a cholinergic and nitrergic drive. Furthermore, fundus relaxation via 5-HT1 receptor activation is mediated through activation of a nitrergic pathway.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9950810     DOI: 10.1152/ajpgi.1999.276.2.G373

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  36 in total

Review 1.  Receptors of the enteric nervous system: potential targets for drug therapy.

Authors:  J Tack
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

2.  Smooth muscle 5-HT2A receptors mediating contraction of porcine isolated proximal stomach strips.

Authors:  P Janssen; N H Prins; A L Meulemans; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

Review 3.  Pharmacology of serotonin: what a clinician should know.

Authors:  F De Ponti
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

Review 4.  Gastroparesis--current concepts and considerations.

Authors:  William L Hasler
Journal:  Medscape J Med       Date:  2008-01-23

Review 5.  Gastroparesis: current diagnostic challenges and management considerations.

Authors:  Shamaila Waseem; Baharak Moshiree; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

Review 6.  New developments in the treatment of functional dyspepsia.

Authors:  Vincenzo Stanghellini; Fabrizio De Ponti; Roberto De Giorgio; Giovanni Barbara; Cesare Tosetti; Roberto Corinaldesi
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 7.  Frontiers in functional dyspepsia.

Authors:  Noel R Fajardo; Filippo Cremonini; Nicholas J Talley
Journal:  Curr Gastroenterol Rep       Date:  2005-08

Review 8.  Current management strategies and emerging treatments for functional dyspepsia.

Authors:  Michael Camilleri; Vincenzo Stanghellini
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-05       Impact factor: 46.802

9.  In vivo characterization of 5-HT1A receptor-mediated gastric relaxation in conscious dogs.

Authors:  P Janssen; N H Prins; B Moreaux; A L Meulemans; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

10.  5-HT7 receptor efficacy distribution throughout the canine stomach.

Authors:  Pieter Janssen; Nicolaas H Prins; Pieter J Peeters; Klaas P Zuideveld; Romain A Lefebvre
Journal:  Br J Pharmacol       Date:  2004-08-31       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.